SCHEMBL24529326

SCHEMBL24529326

CCNCc1cc(Cl)c(OC)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.43
HTR1D P28221 1/20 0.43
HTR1B P28222 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
HTR7 P34969 1/20 0.43
HTR2B P41595 1/20 0.43
HTR5A P47898 1/20 0.43
HTR6 P50406 1/20 0.43
PGK1 P00558 4/20 0.42
GSK3B P49841 1/20 0.42
MAP4K2 Q12851 1/20 0.42
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 3/20 0.39
PKM P14618 1/20 0.39
GAA P10253 3/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12467200 0.81 PGK1 (0.40) PGK1GSK3BMAP4K2ALDH1A1KMT2A
SCHEMBL24386891 0.81 HTR2A (0.45) HTR1AHTR1DHTR1BHTR2AHTR2C
SCHEMBL30716907 0.78 NPC1 (0.38) PGK1GSK3BMAP4K2ALDH1A1KMT2A
SCHEMBL6607812 0.78 NPC1 (0.38) PGK1GSK3BMAP4K2ALDH1A1KMT2A
SCHEMBL15142051 0.71 GAA (0.42) ALDH1A1GAAKDM4ETDP1LMNA
SCHEMBL15142703 0.71 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2LMNAMAPTTP53
SCHEMBL24529330 0.70 ALDH1A1 (0.36) HTR1AHTR1DHTR1BHTR2AHTR2C
SCHEMBL15591654 0.70 DPP4 (0.47) ALDH1A1KMT2AGAAKDM4EMEN1
SCHEMBL20225783 0.69 NPC1 (0.43) PGK1GSK3BMAP4K2ALDH1A1KMT2A
SCHEMBL16200298 0.69 ALDH1A1 (0.47) HTR1AHTR1DHTR1BHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022132696-A1 UREA OREXIN RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2022-06-23 WO disclosed